Institute of Maternal and Children Health, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Department of Pediatrics, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Chemosphere. 2023 Jan;311(Pt 1):136940. doi: 10.1016/j.chemosphere.2022.136940. Epub 2022 Oct 20.
Chlorinated polyfluorinated ether sulfonic acids (Cl-PFESA) and perfluorobutane sulfonate (PFBS), used as perfluorooctanesulfonate (PFOS) alternatives, were indicated as thyroid hormone disruptive toxicants in experimental studies. However, it is unclear whether prenatal exposure to Cl-PFESA and PFBS affects neonatal thyroid stimulating hormone (TSH) in human.
To disclose the relationships between prenatal Cl-PFESAs and PFBS exposure and neonatal thyroid-stimulating hormone (TSH) levels based on a perspective cohort study.
A total of 1015 pairs of mother and newborn were included from an ongoing birth cohort study in Wuhan, China, between 2013 and 2014. Six PFASs in cord blood sera and TSH concentration in neonatal postpartum heel sticks blood were quantified. Mixed linear and weighted quantile sum (WQS) regression models were applied to assess the individual and combination effects of PFASs exposure on neonatal TSH levels with multiple covariates adjustments.
After adjusting for potential confounders and other five PFASs, for each 1-ng/mL increase of PFBS or 8:2 Cl-PFESA, was negatively associated with 25.90% (95%CI: 37.37%, -12.32%; P < 0.001) and 27.19% (95%CI: 46.15%, -1.55%; P = 0.033) change in TSH in male but not female infants, respectively. No significant association was found between other PFASs exposure and neonatal TSH. Higher PFAS mixture in cord blood was significantly associated with decrease TSH concentration in all newborns (β = -0.36; 95%CI: 0.58, -0.13; P = 0.001) identified by WQS regression model. PFBS, PFOS and 6:2 Cl-PFESA were the major contributors to the neonatal TSH decrement with the weights of 56.50%, 18.71%, 12.81% among PFAS mixture, respectively.
our prospective cohort study suggested a negative association of cord serum PFBS and 8:2 CI-PFESA with TSH concentration in newborns, especially for boys. Additional studies are required to elaborate on the underlying biological mechanisms, especially for PFBS.
氯代全氟醚磺酸(Cl-PFESA)和全氟丁烷磺酸(PFBS)作为全氟辛烷磺酸(PFOS)的替代品,在实验研究中被认为是甲状腺激素干扰毒物。然而,目前尚不清楚产前接触 Cl-PFESA 和 PFBS 是否会影响人类新生儿的促甲状腺激素(TSH)。
基于前瞻性队列研究,揭示产前 Cl-PFESAs 和 PFBS 暴露与新生儿促甲状腺激素(TSH)水平之间的关系。
本研究共纳入了 2013 年至 2014 年期间在中国武汉进行的一项正在进行的出生队列研究中的 1015 对母婴。在新生儿产后足跟采血中定量检测脐带血清中 6 种 PFASs 和 TSH 浓度。采用混合线性和加权和(WQS)回归模型,调整潜在混杂因素和其他 5 种 PFASs 后,评估 PFASs 暴露对新生儿 TSH 水平的个体和联合效应。
在调整了潜在混杂因素和其他 5 种 PFASs 后,PFBS 或 8:2 Cl-PFESA 每增加 1ng/mL,男性新生儿 TSH 分别降低 25.90%(95%CI:37.37%,-12.32%;P<0.001)和 27.19%(95%CI:46.15%,-1.55%;P=0.033),但在女性新生儿中未发现显著相关性。其他 PFASs 暴露与新生儿 TSH 无显著相关性。WQS 回归模型显示,脐带血中更高的 PFAS 混合物与所有新生儿 TSH 浓度降低显著相关(β=-0.36;95%CI:0.58,-0.13;P=0.001)。PFBS、PFOS 和 6:2 Cl-PFESA 分别占 PFAS 混合物的 56.50%、18.71%和 12.81%,是新生儿 TSH 降低的主要贡献者。
我们的前瞻性队列研究表明,脐带血清 PFBS 和 8:2 Cl-PFESA 与新生儿 TSH 浓度呈负相关,尤其是男婴。需要进一步的研究来阐明潜在的生物学机制,特别是对于 PFBS。